Biotechnology Services Market by Service Type, End-Users

List of Tables

The Biotechnology Services Market was valued at USD 193.05 billion in 2023, expected to reach USD 214.69 billion in 2024, and is projected to grow at a CAGR of 11.60%, to USD 416.25 billion by 2030.

The Biotechnology Services market encompasses a wide range of services such as bioprocessing, drug discovery, DNA sequencing, genomics, and proteomics, aimed at supporting life sciences companies and advancing healthcare solutions. The necessity for these services arises from the increasing demand for personalized medicine, breakthroughs in biopharmaceuticals, and the pressing need for innovative healthcare solutions. These services are applied across various stages of pharmaceutical and biotechnological product development, from research and pre-clinical trials to regulatory approvals and post-market studies, supporting organizations like research institutions, healthcare providers, and pharmaceutical companies. Key growth influencers in this market include advancements in genetic engineering, robust investments in biotechnology R&D, and a growing prevalence of chronic diseases necessitating innovative treatments. Opportunities abound in areas such as CRISPR technology, regenerative medicine, and bioinformatics; stakeholders can harness these by investing in collaborative partnerships, enhancing service portfolios, and focusing on emerging markets. Nonetheless, limitations persist, such as stringent regulatory landscapes, high operational costs, and ethical concerns around genetic modifications, which can impede market expansion. Additionally, access to skilled professionals and data management challenges present significant hurdles. Innovative research areas with high potential for business growth include developing affordable sequencing methods, improving bioprocessing efficiencies, and integrating AI and machine learning for predictive analytics in drug discovery. For market entrants and existing players, insights into market dynamics reveal a promising but competitive landscape where adaptability, technological prowess, and strategic alliances will be essential for sustained growth. Emphasizing patient-centric approaches and sustainability practices may also offer distinct advantages in line with global trends towards eco-conscious and human-centered healthcare solutions. Overall, the biotechnology services market presents a vibrant environment ripe with potential for those ready to navigate its complexities with innovative strategies.

KEY MARKET STATISTICS
Base Year [2023]	USD 193.05 billion
Estimated Year [2024]	USD 214.69 billion
Forecast Year [2030]	USD 416.25 billion
CAGR (%)	11.60%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biotechnology Services Market

The Biotechnology Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Increasing outsourcing of drug development activities by pharmaceutical companies
- Growing rate of academic research activities and need for efficient facilities
- Rising expansion of contract research and manufacturing services
Market Restraints
- Concerns over performance, quality and confidentiality of outsourcing services
Market Opportunities
- Advancements in biotechnology instruments and techniques
- Emerging funding and investment activities in biotechnology research
Market Challenges
- Stringent regulatory compliances for biotechnology outsourcing services

Porter's Five Forces: A Strategic Tool for Navigating the Biotechnology Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biotechnology Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biotechnology Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biotechnology Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biotechnology Services Market

A detailed market share analysis in the Biotechnology Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biotechnology Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biotechnology Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biotechnology Services Market

A strategic analysis of the Biotechnology Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biotechnology Services Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Almac Group Limited, AnaBioTec NV, Avance Clinical Pty Ltd., Azenta Life Sciences, Becton, Dickinson and Company, Biogen Inc., BioIVT LLC, Caidya, Catalent, Inc., Charles River Laboratories International, Inc., CMIC Group, Contract Pharmacal Corp., Crown Bioscience, Inc., Danaher Corporation, Eurofins Scientific Limited, GE HealthCare Technologies Inc., GenScript Biotech Corporation, ICON PLC, ITR Laboratories Canada, Kaneka Corporation, Laboratory Corporation of America Holdings, Merck KGaA, Novartis AG, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Biotechnology Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Service Type, market is studied across Cell Processing & Isolation, Donor Recruitment, Food Biotechnology Services, Prevention & Disease Control, Public Engagement Activities, and Tissue Collection.
Based on End-Users, market is studied across Biotechnology Companies, Clinical Research Organizations(CROs), and Contract Manufacturers Organizations (CMOs).
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-521BAA36EA71

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing outsourcing of drug development activities by pharmaceutical companies
  - 5.1.1.2. Growing rate of academic research activities and need for efficient facilities
  - 5.1.1.3. Rising expansion of contract research and manufacturing services
- 5.1.2. Restraints
  - 5.1.2.1. Concerns over performance, quality and confidentiality of outsourcing services
- 5.1.3. Opportunities
  - 5.1.3.1. Advancements in biotechnology instruments and techniques
  - 5.1.3.2. Emerging funding and investment activities in biotechnology research
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulatory compliances for biotechnology outsourcing services
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Biotechnology Services Market, by Service Type

6.1. Introduction
6.2. Cell Processing & Isolation
6.3. Donor Recruitment
6.4. Food Biotechnology Services
6.5. Prevention & Disease Control
6.6. Public Engagement Activities
6.7. Tissue Collection

7. Biotechnology Services Market, by End-Users

7.1. Introduction
7.2. Biotechnology Companies
7.3. Clinical Research Organizations(CROs)
7.4. Contract Manufacturers Organizations (CMOs)

8. Americas Biotechnology Services Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Biotechnology Services Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Biotechnology Services Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Agilent Technologies, Inc.
2. Almac Group Limited
3. AnaBioTec NV
4. Avance Clinical Pty Ltd.
5. Azenta Life Sciences
6. Becton, Dickinson and Company
7. Biogen Inc.
8. BioIVT LLC
9. Caidya
10. Catalent, Inc.
11. Charles River Laboratories International, Inc.
12. CMIC Group
13. Contract Pharmacal Corp.
14. Crown Bioscience, Inc.
15. Danaher Corporation
16. Eurofins Scientific Limited
17. GE HealthCare Technologies Inc.
18. GenScript Biotech Corporation
19. ICON PLC
20. ITR Laboratories Canada
21. Kaneka Corporation
22. Laboratory Corporation of America Holdings
23. Merck KGaA
24. Novartis AG
25. Siemens Healthcare GmbH
26. Thermo Fisher Scientific Inc.